Allergan expands dry eye portfolio with launch of Refresh Optive Gel Drops
In a clinical study, patients report significant reduction in dry eye symptoms in just 30 days of usage.
Allergan has launched the over-the-counter artificial tear Refresh Optive Gel Drops, a new aqueous gel expertly designed for patients who need or desire a more viscous artificial tear option to relieve their Dry Eye symptoms. From Refresh, the creators of the number one doctor recommended brand of artificial tears, new Refresh Optive Gel Drops are formulated with Glycerin and a unique blend of the active ingredient CMC which binds to the eye surface to provide long-lasting relief from Dry Eye discomfort.
"With Refresh Optive Gel Drops, eye care providers now have an even more comprehensive line of artificial tear types to offer to their patients with individual needs," said Joseph Vehige, O.D., Vice President of Consumer Eye Care Research & Development,Allergan. "Leveraging the latest technology from Optive, the new multi-dose Gel Drops help dry eye patients find comfort any time, day or night."
An estimated 25 million people in the US suffer from dry eye symptoms, including irritation, blurred vision, sensitivity to light, burning, stinging, dryness and excessive tearing. In a multicenter, double-masked, randomized study, dry eye patients (n=94) using Refresh Optive Gel Drops showed a statistically significant reduction in symptoms at day 30. The innovative Gel Drops formula delivers a shear-thinning effect that spreads quickly and evenly over the eye surface to relieve dry eye symptoms while creating a soothing shield to protect the eye surface from hypertonic stress.
"Dry eye is a reduction in your eyes' ability to produce or maintain sufficient quantity and quality of natural tears. Tears are important to the overall health of our eyes and our vision. My patients suffering from dry eye symptoms often ask me for a more hydrating artificial tear that will give them longer-lasting relief and comfort," said Milton M. Hom, OD, FAAO. "I like Refresh Optive Gel Drops because of its advanced aqueous gel formulation that helps the ocular surface maintain its moisture level. Refresh Optive products are effective in reducing dry eye symptoms and convenient to use with no shaking required — just drop and go."
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance